Cargando…
Effect of low-dose Levamlodipine Besylate in the treatment of vascular dementia
Vascular dementia (VaD) is a complex disorder caused by reduced blood flow in the brain. However, there is no effective pharmacological treatment option available until now. Here, we reported that low-dose levamlodipine besylate could reverse the cognitive impairment in VaD mice model of right unila...
Autores principales: | Yao, Kai-Xin, Lyu, Hang, Liao, Mei-Hua, Yang, Lin, Gao, Yin-Ping, Liu, Qi-Bing, Wang, Cheng-kun, Lu, Ying-Mei, Jiang, Guo-Jun, Han, Feng, Wang, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890753/ https://www.ncbi.nlm.nih.gov/pubmed/31796756 http://dx.doi.org/10.1038/s41598-019-47868-0 |
Ejemplares similares
-
Clinical assessment of levamlodipine besylate combination therapy for essential hypertension: A protocol for systematic review and meta-analysis
por: Dai, Guo-Yao, et al.
Publicado: (2022) -
Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study
por: Li, Xin, et al.
Publicado: (2020) -
The effective doses of remimazolam besylate in the procedural sedation of endoscopic retrograde cholangiopancreatography
por: Tan, Dan‐Dan, et al.
Publicado: (2022) -
Venlafaxine besylate monohydrate
por: Corvalan, Carolina H., et al.
Publicado: (2013) -
Effect of administration of low‐dose irbesartan and hydrochlorothiazide combined with levamlodipine at different times on the circadian rhythm of blood pressure and the levels of MMPs and TIMPs in non‐dipper patients with grade 1 and 2 hypertension
por: Yan, Peiling, et al.
Publicado: (2023)